KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Invested Capital (2016 - 2025)

Eli Lilly's Return on Invested Capital history spans 17 years, with the latest figure at 0.52% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 13.0% year-over-year to 0.52%; the TTM value through Dec 2025 reached 0.52%, up 13.0%, while the annual FY2025 figure was 0.44%, 3.0% up from the prior year.
  • Return on Invested Capital reached 0.52% in Q4 2025 per LLY's latest filing, down from 1.9% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 17.54% in Q3 2023 to a low of 0.24% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 1.56%, with a median of 0.59% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: soared 1711bps in 2023, then plummeted -1711bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.38% in 2021, then surged by 45bps to 0.56% in 2022, then grew by 11bps to 0.62% in 2023, then plummeted by -36bps to 0.39% in 2024, then soared by 32bps to 0.52% in 2025.
  • Per Business Quant, the three most recent readings for LLY's Return on Invested Capital are 0.52% (Q4 2025), 1.9% (Q3 2025), and 1.22% (Q2 2025).